Journal Report

Pharmacology and Therapeutics

Download PDF
Journal Information
Journal Title
Pharmacology and Therapeutics
Publisher
Elsevier Inc.
ISSN
0163-7258
E-ISSN
1879-016X
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Cell death-induced chronic inflammation as a therapeutic target for metabolic dysfunction-associated steatohepatitis
Takayoshi Suganami, Miyako Tanaka, Michiko Itoh
2026-12 Vol. 288 Pages 109123
DOI: 10.1016/j.pharmthera.2026.109123
Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap
Jinwei Zhang, Boris S. Shenkman
2026-12 Vol. 288 Pages 109129
DOI: 10.1016/j.pharmthera.2026.109129
The regulatory and therapeutic potential of transposable elements in cancer and inflammatory diseases
Keman Xu, Juanjuan Liu, Fatma Saaoud et al.
2026-12 Vol. 288 Pages 109128
DOI: 10.1016/j.pharmthera.2026.109128
Apolipoprotein E in spinal cord injury: mechanisms of lipid dysregulation, neuroinflammation, and opportunities for repair
Ciara M. Walsh, Maria S. Ioannou, Faith H. Brennan
2026-12 Vol. 288 Pages 109122
DOI: 10.1016/j.pharmthera.2026.109122
Nucleic acid therapeutics for reinvigorating p53 function in glioblastoma: concepts, limitations and recent advances
Alexander Hagstotz, Susanne Michen, Achim Aigner et al.
2026-12 Vol. 288 Pages 109134
DOI: 10.1016/j.pharmthera.2026.109134
Sinoatrial node dysfunction: molecular mechanisms, arrhythmogenesis, and translational pathways toward precision therapy
Nam V. Truong, Julianna N. Quinn, Mark Returan et al.
2026-12 Vol. 288 Pages 109131
DOI: 10.1016/j.pharmthera.2026.109131
Neuroregulation as a modulatory force in immune checkpoint inhibitor resistance: mechanistic neuro-immune crosstalk informing biomarker-led diagnosis and targetable therapeutic sensitization
Mingze Ma, Gaoyong Hu, Yuankai Hao et al.
2026-12 Vol. 288 Pages 109124
DOI: 10.1016/j.pharmthera.2026.109124
Galectin-3 and its inhibitors: Overview and perspectives
Shuanglin Liu, Shengjie Wu, Fei He et al.
2026-12 Vol. 288 Pages 109125
DOI: 10.1016/j.pharmthera.2026.109125
Clusterin as a therapeutic agent: Bridging the gap in brain and eye research
Bushra Zaman, Avinash Soundararajan, Padmanabhan P. Pattabiraman et al.
2026-12 Vol. 288 Pages 109108
DOI: 10.1016/j.pharmthera.2026.109108
The rhythm of pressure: Circadian disruption and chronotherapy
Kan Gao, Chunyang Zhao, Tao Yang et al.
2026-12 Vol. 288 Pages 109127
DOI: 10.1016/j.pharmthera.2026.109127
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 29, 2026 06:43